Patient Affordability: The Ongoing Crisis and the Opportunities for Pharma - Archive
In this webinar, Kantar Health examines patient affordability in cancer care, which is one of the leading non-clinical attributes in the oncologist’s decision to choose one therapeutic agent over another. Affordability will continue to grow in importance as insurance benefit designs shift greater cost burden. Financial assistance programs include a range of assistance sources that help patients afford their treatment.
Well-designed manufacturer-direct programs help keep prescriber decisions focused on clinical rather than financial considerations. Financial assistance programs are evolving and oncology practices place increasing value on them. Minimizing practice burden should be a key consideration in structuring program access, information, enrollment, and qualification. Developing strategies to support underinsured patients in the state exchanges will be essential to ensure continued access and adherence for this patient population.
Debbie Warner will be joined by Lynn Humphrey and Patricia Goldsmith on a panel that will share and discuss marketplace trends and provide perspectives from both oncology practices and charitable foundations that assist patients in need.
Chief Executive Officer
Cancer Center of Santa Barbara
Vice President, Oncology Commercial Strategies